¼ö¼úÁß Dextran - 40 Åõ¿©¿¡ ÀÇÇÑ °ú¹Î¹ÝÀÀ Ä¡Çè
Anaphylactic Reaction Associated with the Use of Dextran - 40
´ëÇѱ¸±ÞÀÇÇÐȸÁö 1995³â 10±Ç 2È£ p.119 ~ 121
¹ÚÂùÁø, ±è¸í¼ö, ±èº°¾Æ, ÀÓ¼ºÁø, ÀÓÈ£, Á¤¼º¼ö,
¼Ò¼Ó »ó¼¼Á¤º¸
¹ÚÂùÁø ( )
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¸¶Ãë°úÇб³½Ç
±è¸í¼ö ( )
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¸¶Ãë°úÇб³½Ç
±èº°¾Æ ( )
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¸¶Ãë°úÇб³½Ç
ÀÓ¼ºÁø ( )
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¸¶Ãë°úÇб³½Ç
ÀÓÈ£ ( )
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¸¶Ãë°úÇб³½Ç
Á¤¼º¼ö ( )
Àü³²´ëÇб³ Ä¡°ú´ëÇÐ ¸¶Ãë°úÇб³½Ç
KMID : 0356019950100020119
Abstract
Dextran-40 has been used widely as a plasma volume expander and is being used increasingly for prophylactic antithrombotic therapy in surgical patients, who are at high risk of thrombo-embolic complications. But it has severe complications such as allergic reaction and anaphylaxis.
We experienced a case in which an anaphylactic reaction associated with the infusion of dextran-40 during spinal anesthesia for orthopedic surgery in a 62 year-old male patient. It is important to remember that anaphylaxis associated with infusion of dextran may be occured, although it is rare.
Å°¿öµå
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸